Boeckh, Michael

Invasive aspergillosis in allogeneic stem cell transplant recipients: Changes in epidemiology and risk factors

Marr, K. A., Carter, R. A., Boeckh, M., Martin, P., & Corey, L. (2002) · Blood

Antifungal resistance and susceptibilityHematopoietic Stem Cell Transplantation

Cited by 957

Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning

Fukuda, T., Boeckh, M., Carter, R. A., Sandmaier, B. M., Maris, M. B., Maloney, D. G., Martin, P. J., Storb, R. F., & Marr, K. A. (2003) · Blood

Antifungal resistance and susceptibilityHematopoietic Stem Cell Transplantation

Cited by 465

Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation

Bochud, P.-Y., Chien, J. W., Marr, K. A., Leisenring, W. M., Upton, A., Janer, M., Rodrigues, S. D., Li, S., Hansen, J. A., Zhao, L. P., et al. (2008) · New England Journal of Medicine

Antifungal resistance and susceptibilityImmune Response and Inflammation

Cited by 453

Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation

Seydoux, E., Homad, L. J., MacCamy, A. J., Parks, K. R., Hurlburt, N. K., Jennewein, M. F., Akins, N. R., Stuart, A. B., Wan, Y.-H., Feng, J., et al. (2020) · Immunity

SARS-CoV-2 and COVID-19 ResearchMonoclonal and Polyclonal Antibodies Research

Cited by 364

A human coronavirus evolves antigenically to escape antibody immunity

Eguia, R., Crawford, K. H. D., Stevens-Ayers, T., Kelnhofer-Millevolte, L., Greninger, A. L., Englund, J. A., Boeckh, M. J., & Bloom, J. D. (2020) · PLoS Pathogens

SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studies

Cited by 258

Efficacy of transfusion with granulocytes from G-CSF/dexamethasone–treated donors in neutropenic patients with infection

Price, T. H., Boeckh, M., Harrison, R. W., McCullough, J., Ness, P. M., Strauss, R. G., Nichols, W. G., Hamza, T. H., Cushing, M. M., King, K. E., et al. (2015) · Blood

Neutropenia and Cancer InfectionsBlood disorders and treatments

Cited by 254

Phase I/II trial of neutrophil transfusions from donors stimulated with G-CSF and dexamethasone for treatment of patients with infections in hematopoietic stem cell transplantation

Price, T. H., Bowden, R. A., Boeckh, M., Bux, J., Nelson, K., Liles, W. C., & Dale, D. C. (2000) · Blood

Hematopoietic Stem Cell TransplantationNeutropenia and Cancer Infections

Cited by 253

Geoclimatic influences on invasive aspergillosis after hematopoietic stem cell transplantation

Panackal, A. A., Li, H., Kontoyiannis, D. P., Mori, M., Perego, C. A., Boeckh, M., & Marr, K. A. (2010) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityNeutropenia and Cancer Infections

Cited by 169

Use of long-term suppressive acyclovir after hematopoietic stem-cell transplantation: impact on herpes simplex virus (HSV) disease and drug-resistant HSV disease.

Erard, V., Wald, A., Corey, L., Leisenring, W. M., & Boeckh, M. (2007) · The Journal of Infectious Diseases

Herpesvirus Infections and TreatmentsCytomegalovirus and herpesvirus research

Cited by 121

Incidence and outcomes of bloodstream infections among hematopoietic cell transplant recipients from species commonly reported to be in over-the-counter probiotic formulations

Cohen, S. A., Woodfield, M. C., Boyle, N., Stednick, Z., Boeckh, M., & Pergam, S. A. (2016) · Transplant Infectious Disease

Probiotics and Fermented FoodsNeutropenia and Cancer Infections

Cited by 75

Impact of human cytomegalovirus (CMV) infection on immune response to pandemic 2009 H1N1 influenza vaccine in healthy adults

Wald, A., Selke, S., Magaret, A., & Boeckh, M. (2013) · Journal of Medical Virology

Cytomegalovirus and herpesvirus researchInfluenza Virus Research Studies

Cited by 50